Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Retatrutide is an investigational once-weekly injectable triple agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, targeting appetite, glucose metabolism, and energy expenditure through a single agent
Who Its For: GLP-1 users
A separate late-stage cardiovascular outcomes trial is ongoing
This multi-pathway approach aims to regulate metabolism more powerfully than single- or dual-action compounds
This is the ladder documented in the Wegovy prescribing information and mirrored in the STEP trial program
Signs that your anticoagulant dose may need adjustment include unusual bruising, bleeding gums, or changes in INR
US$ 27.72
US$ 26.79
US$ 29.04
US$ 29.30
![Henry Meds Semaglutide Review [2026]](https://innerbody.imgix.net/henry-semaglutide-with-ondansteron-close-up.jpg?auto=format,compress&fit=max&w=826&q=75)
US$ 29.78
US$ 21.48
US$ 28.75
US$ 28.12
US$ 26.32
US$ 25.45
